Nathan Lavey

Nathan Lavey has a diverse work experience spanning various scientific roles. Nathan is currently working at Frontier Medicines as a Scientist I since August 2022. Before that, they worked at FogPharma as a Scientist I from September 2021 to July 2022. Prior to that, Nathan was an ORISE Postdoctoral Fellow at the FDA from September 2020 to September 2021. Nathan also served as a Cancer Research Training Award Postdoctoral Fellow at the National Cancer Institute (NCI) from May 2019 to September 2020. Nathan's earlier experiences include being a Graduate Student Elect to the SSRL's User Executive Committee at the Stanford Synchrotron Radiation Lightsource from October 2017 to May 2019, a Graduate Research Assistant at the University of Oklahoma from August 2013 to May 2019, and a Laboratory Technician / Database Administrator at Boston Heart Diagnostics from November 2011 to June 2013. Nathan started their career as a Research Associate at the Center to Advance Molecular Interaction Science (CAMIS) from June 2009 to May 2011.

Nathan Lavey received their High School Diploma from Hollis Brookline High School in 2007. Nathan then pursued a Bachelor's degree in Biochemistry at the University of New Hampshire from 2009 to 2011. Continuing their education, they earned a Doctor of Philosophy (Ph.D.) in Biochemistry from the University of Oklahoma, completing their studies in 2019.